Work

Abstract B040: Combined treatment and metabolomics reveal mechanism underlying the synergy of ribitol and shikonin against breast cancer

Year: 2025

Type: conference-abstract

Source: Molecular Cancer Therapeutics

DOI: 10.1158/1535-7163.targ-25-b040

Author: Ravi Doddapaneni

Language: English

Topic: Bioactive Compounds and Antitumor Agents

Subfield: Toxicology

Field: Pharmacology, Toxicology and Pharmaceutics

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4415444769

Cites:

Cited by:

Related to: